[Review and updating of the diagnostic sensibility of the dexamethasone suppression test and urinary determination of phenylethylamine and 3-methoxy-4-hydroxyphenylethylglycol in the diagnosis of endogenous depression].
60 endogenous depressive patients (DSM III: 296.2x, 3x, 296.5x) were studied according to the following diagnostic techniques: DST (Carroll's standardization), Phenyl-ethyl-amine (PEA) urinary quantification (Spatz's technique) and 3-Methoxy-4-Hydroxyphenylethyl Glycol (MHPG) urinary quantification (Bigelow's technique). Seven groups were thus obtained according to their being positive in, at least, one of those determinations. The above mentioned techniques allow the finest of discriminations since 5% of the patients only kept undetected. The critical path analysis to this conclusion is discussed.
Ciprian-Ollivier
J
J
Boullosa
O
O
Bakmas
M C
MC
D000293:Adolescent; D000328:Adult; D000368:Aged; D003866:Depressive Disorder / Q000175:diagnosis*; D003907:Dexamethasone; D005260:Female; D006018:Glycols / Q000652:urine*; D006801:Humans; D008297:Male; D008734:Methoxyhydroxyphenylglycol / Q000652:urine*; D008875:Middle Aged; D010627:Phenethylamines / Q000652:urine*
D006018:Glycols; D010627:Phenethylamines; D008734:Methoxyhydroxyphenylglycol; D003907:Dexamethasone
Revisión y actualización de la sensibilidad diagnóstica del test de la supresión de la dexametasona y de la determinación de feniletilamina y ácido 3-metoxi-4-hidroxi-feniletilglicol urinarios en el diagnóstico de la depresión endógena.